Table 4.
Reported medical history among study group and odds ratios (95% CI) for zones 1 vs 3 and zones 2 vs 3.
| Somatic Disorders | All Zones N=742 | Zone 1 n1=168 | Zone 2 n2=253 | Zone 3 n3=321 | P* | Zones 1 vs 3† | Zones 2 vs 3‡ |
|---|---|---|---|---|---|---|---|
| CD: Count by Disorder
|
Odds Ratio (95 % CI) | ||||||
| CD (%N) | CD (%n1) | CD (%n2) | CD (%n3) | ||||
| Hypertension | 77 (11.3) | 18 (14.9) | 19(8.0) | 40 (12.5) | .102 | 1.22 (0.67–2.23)a | 1.65 (0.93–2.92)a |
| Cardiac disorder | 90(13.1) | 20 (16.5) | 16(6.6) | 54 (16.8) | .001 | 0.98 (0.56–1.72)a | 2.87 (1.60–5.15)b |
| Headaches | 215 (30.0) | 81 (54.7) | 46 (18.6) | 88 (27.4) | .001 | 3.2 (2.13–4.80)c | 1.65 (1.10–2.47)d |
| Respiratory disorder | 106 (15.1) | 42 (31.3) | 25 (10.1) | 39 (12.2) | .001 | 3.30 (2.02–5.42)c | 1.23 (0.72–2.09)a |
| Asthma | 31 (4.6) | 11 (9.8) | 4(1.7) | 16 (5.0) | .003 | 2.08 (0.93–4.62)a | 3.12 (1.03–9.46)d |
| Ear/nose/throat disorder | 91 (13.3) | 23 (19.5) | 19 (7.8) | 49 (15.3) | .003 | 1.34 (0.78–2.32)a | 2.13 (1.22–3.73)e |
| Ulcer | 42 (6.2) | 13 (11.4) | 11 (4.5) | 18 (5.6) | .036 | 2.17 (1.03–4.58)d | 1.26 (0.58–2.70)a |
| Gastrointestinal disorder | 253 (36.0) | 58 (43.0) | 70 (28.3) | 125 (38.9) | .006 | 1.18 (0.79–1.78)a | 1.61 (1.13–2.30)e |
| Diabetes | 24 (3.6) | 7 (6.3) | 5 (2.2) | 12 (3.7) | .167 | 1.72 (0.66–4.47)e | 1.74 (0.60–5.01)a |
| Genitourinary disorder | 131 (18.5) | 50(35.5) | 35(14.1) | 46(14.3) | .001 | 3.28 (2.06–5.23)c | 1.02 (0.63–1.64)a |
| Hematology disorder | 9 (1.3) | 4 (3.6) | 1(0.4) | 4 (1.3) | .051 | 2.96 (0.73–12.05)a | 3.07(0.34–27.61)a |
| Rheumatology disorder | 87 (12.8) | 27 (23.7) | 12(4.9) | 48 (15.0) | .001 | 1.77 (1.04–3.00)d | 3.38 (1.76–6.53)b |
| Musculoskeletal disorder | 195 (27.3) | 78 (53.4) | 55 (22.2) | 62 (19.3) | .001 | 4.79 (3.13–7.35)c | 0.84 (0.56–1.26)a |
| Chronic fatigue | 56(8.1) | 38 (30.2) | 18 (7.4) | 0 (0.0) | .001 | 277 (16.6–4558.60)c | 0.02 (0.001–0.32)c |
| Allergies | 253 (36.6) | 61 (47.3) | 68 (28.2) | 124 (38.6) | .001 | 1.42 (0.94–2.15)e | 1.60 (1.12–2.29)e |
| Skin disorders v | 181 (26.6) | 44 (37.6) | 40 (16.5) | 97 (30.2) | .001 | 1.39 (0.89–2.17)a | 2.19 (1.45–3.31)b |
| Miscellaneous disorders | 66 (5.9) | 23 (17.0) | 17 (4.4) | 26 (4.4) | .001 | 5.29 (2.55–10.98)c | 0.84 (0.36–1.93)a |
Percentages are based on non-missing data.
*
Represents the P value for overall χ2 test.
†
OR represents the magnitude of association between medical condition and zone 1 where zone 3 Is the reference zone.
‡
OR represents the magnitude of association between medical condition and zone 2 where zone 3 Is the reference zone.
Note: Zone 1 = In Kuwait; Zone2=100–190 km from Kuwait; Zone 3=360 km from Kuwait.
a
No significant difference
b
P<.001
c
P<0001
d
P<.05
e
P<.01